Global Medical REIT (NYSE:GMRE) Now Covered by Analysts at KeyCorp

Analysts at KeyCorp initiated coverage on shares of Global Medical REIT (NYSE:GMRE) in a report released on Monday, Analyst Price Targets reports. The brokerage set an “overweight” rating and a $17.00 price target on the stock. KeyCorp’s price objective would indicate a potential upside of 12.81% from the stock’s previous close.

Several other analysts also recently commented on GMRE. B. Riley increased their target price on shares of Global Medical REIT from $16.00 to $18.00 and gave the company a “buy” rating in a report on Tuesday, June 15th. Zacks Investment Research upgraded shares of Global Medical REIT from a “sell” rating to a “hold” rating in a report on Tuesday, May 25th. Finally, Colliers Securities started coverage on shares of Global Medical REIT in a report on Friday, July 9th. They set a “buy” rating and a $18.00 price objective for the company. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $16.80.

Shares of GMRE stock opened at $15.07 on Monday. The firm has a 50-day moving average of $15.33 and a 200-day moving average of $14.69. The company has a market cap of $967.45 million, a P/E ratio of -115.92, a P/E/G ratio of 2.01 and a beta of 0.73. The company has a debt-to-equity ratio of 0.79, a current ratio of 0.17 and a quick ratio of 0.17. Global Medical REIT has a one year low of $12.11 and a one year high of $16.07.

Global Medical REIT (NYSE:GMRE) last announced its earnings results on Tuesday, August 3rd. The company reported $0.04 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.22 by ($0.18). Global Medical REIT had a net margin of 0.15% and a return on equity of 0.03%. As a group, research analysts expect that Global Medical REIT will post 0.96 earnings per share for the current fiscal year.

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Nuveen Asset Management LLC increased its stake in shares of Global Medical REIT by 1,529.0% in the first quarter. Nuveen Asset Management LLC now owns 3,101,067 shares of the company’s stock worth $40,655,000 after purchasing an additional 2,910,699 shares in the last quarter. Aew Capital Management L P purchased a new position in shares of Global Medical REIT in the second quarter worth about $41,882,000. Prudential Financial Inc. increased its stake in shares of Global Medical REIT by 63.1% in the first quarter. Prudential Financial Inc. now owns 3,638,242 shares of the company’s stock worth $47,697,000 after purchasing an additional 1,407,419 shares in the last quarter. BlackRock Inc. increased its stake in shares of Global Medical REIT by 19.5% in the second quarter. BlackRock Inc. now owns 4,655,462 shares of the company’s stock worth $68,714,000 after purchasing an additional 759,769 shares in the last quarter. Finally, Adelante Capital Management LLC purchased a new position in shares of Global Medical REIT in the second quarter worth about $10,849,000. Institutional investors and hedge funds own 70.26% of the company’s stock.

Global Medical REIT Company Profile

Global Medical REIT, Inc engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.

Featured Story: What economic reports are most valuable to investors?

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.

Global Medical REIT (NYSE:GMRE) Now Covered by Analysts at KeyCorp

Analysts at KeyCorp initiated coverage on shares of Global Medical REIT (NYSE:GMRE) in a report released on Monday, Analyst Price Targets reports. The brokerage set an “overweight” rating and a $17.00 price target on the stock. KeyCorp’s price objective would indicate a potential upside of 12.81% from the stock’s previous close.

Several other analysts also recently commented on GMRE. B. Riley increased their target price on shares of Global Medical REIT from $16.00 to $18.00 and gave the company a “buy” rating in a report on Tuesday, June 15th. Colliers Securities started coverage on shares of Global Medical REIT in a report on Friday, July 9th. They issued a “buy” rating and a $18.00 target price for the company. Finally, Zacks Investment Research upgraded shares of Global Medical REIT from a “sell” rating to a “hold” rating in a report on Tuesday, May 25th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $16.80.

Shares of GMRE stock opened at $15.07 on Monday. The firm has a 50-day moving average of $15.33 and a 200-day moving average of $14.69. The company has a market cap of $967.45 million, a P/E ratio of -115.92, a P/E/G ratio of 2.01 and a beta of 0.73. The company has a debt-to-equity ratio of 0.79, a current ratio of 0.17 and a quick ratio of 0.17. Global Medical REIT has a one year low of $12.11 and a one year high of $16.07.

Global Medical REIT (NYSE:GMRE) last announced its earnings results on Tuesday, August 3rd. The company reported $0.04 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.22 by ($0.18). Global Medical REIT had a net margin of 0.15% and a return on equity of 0.03%. As a group, research analysts expect that Global Medical REIT will post 0.96 earnings per share for the current fiscal year.

A number of hedge funds and other institutional investors have recently bought and sold shares of GMRE. Nuveen Asset Management LLC increased its holdings in Global Medical REIT by 1,529.0% during the first quarter. Nuveen Asset Management LLC now owns 3,101,067 shares of the company’s stock worth $40,655,000 after buying an additional 2,910,699 shares during the last quarter. Aew Capital Management L P purchased a new position in shares of Global Medical REIT in the second quarter worth about $41,882,000. Prudential Financial Inc. increased its stake in shares of Global Medical REIT by 63.1% in the first quarter. Prudential Financial Inc. now owns 3,638,242 shares of the company’s stock worth $47,697,000 after purchasing an additional 1,407,419 shares in the last quarter. BlackRock Inc. increased its stake in shares of Global Medical REIT by 19.5% in the second quarter. BlackRock Inc. now owns 4,655,462 shares of the company’s stock worth $68,714,000 after purchasing an additional 759,769 shares in the last quarter. Finally, Adelante Capital Management LLC purchased a new position in shares of Global Medical REIT in the second quarter worth about $10,849,000. Institutional investors and hedge funds own 70.26% of the company’s stock.

Global Medical REIT Company Profile

Global Medical REIT, Inc engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.

Featured Story: What economic reports are most valuable to investors?

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.